Effect of Microbial Exposure on Health, Particularly Immune System
NCT03351543 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-11-24
Summary
The effect of microbial exposure on healthy human subjects will be investigated. Changes in cytokine and IgE and vaccine response will be measured. The hypothesis is that microbial exposure increases the measured responses.
Conditions
- Immune System Disorders
Interventions
- BIOLOGICAL
-
microbial inoculate
volunteers will regularly receive microbial inoculate that they do not use orally
Sponsors & Collaborators
-
Tampere University
collaborator OTHER -
University of Helsinki
lead OTHER
Principal Investigators
-
Aki Sinkkonen, Ph D Docent · University of Helsinki
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-06-30
- Completion
- 2017-07-31
Countries
- Finland
More Related Trials
-
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4893 in Healthy Adult Subjects
NCT01769417 ·Status: COMPLETED ·Phase: PHASE1
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the Community
NCT00966446 ·Status: COMPLETED ·Phase: NA
-
Microbiome and Atopy in Mali
NCT07051902 ·Status: RECRUITING
-
Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388 ·Status: COMPLETED ·Phase: PHASE1
-
Antibiotics and Vaccine Immune Responses Study
NCT06148025 ·Status: RECRUITING ·Phase: PHASE4
-
Antimicrobial Resistance (AMR) Study
NCT06944158 ·Status: RECRUITING
-
Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection
NCT01074775 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Staphylococcus Aureus Caught in Action at the Site of Infection
NCT04781569 ·Status: COMPLETED
-
A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection
NCT04784312 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers
NCT00990145 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
NCT01671358 ·Status: COMPLETED
-
Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
NCT04353518 ·Status: UNKNOWN ·Phase: PHASE3
-
Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
NCT04350931 ·Status: UNKNOWN ·Phase: PHASE3
-
An Ecological Analysis of Nontuberculous Mycobacteria in the Geneva Area (2015-2020)
NCT04718571 ·Status: COMPLETED
-
Effects of an Antimicrobial Stewardship (AMS) Program, on the Prevalence of Multidrug-resistant Gram - Negative Pathogens, in an Area of High Consumption of Antibiotics and High Resistance Rates
NCT04261348 ·Status: UNKNOWN
-
A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402
NCT02375256 ·Status: COMPLETED ·Phase: PHASE1
-
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
NCT02281643 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy and Safety of MEDI4893
NCT02296320 ·Status: COMPLETED ·Phase: PHASE2
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Resolution After Staphylococcus Aureus Bacteremia
NCT01879761 ·Status: ACTIVE_NOT_RECRUITING
-
An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
NCT01018641 ·Status: COMPLETED ·Phase: PHASE1
-
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
NCT04345315 ·Status: UNKNOWN